Enzolytics, Inc. (ENZC)
OTCMKTS · Delayed Price · Currency is USD
0.0004
0.00 (0.00%)
At close: Oct 30, 2026
Enzolytics Market Cap
Enzolytics has a market cap or net worth of $1.93 million as of October 30, 2026. It is the 48,038th most valuable company in the world and the 6,430th biggest in the United States. Its market cap has increased by 33.33% in one year.
Market Cap
1.93M
Enterprise Value
n/a
Revenue
46.59K
Global Rank
Country Rank
#6,430 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since December 29, 2008, Enzolytics's market cap has decreased from 106.80M to 1.93M, a decrease of -98.19%. That is a compound annual growth rate of -20.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 1.93M | 33.33% |
| Dec 31, 2025 | 1.45M | -68.42% |
| Dec 31, 2024 | 4.59M | -91.73% |
| Dec 29, 2023 | 55.53M | -46.84% |
| Dec 30, 2022 | 104.44M | -45.90% |
| Dec 31, 2021 | 193.06M | -12.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Emmaus Life Sciences | 2.86M |
| GPL Holdings | 2.56M |
| Abpro Holdings | 2.54M |
| AccuStem Sciences | 2.41M |
| Bioxytran | 2.32M |
| Agentix | 2.12M |
| CASI Pharmaceuticals | 2.06M |
| Vaccinex | 2.01M |